Mode
Text Size
Log in / Sign up

Innovative diagnostic techniques improve risk stratification and specificity in food allergy diagnosisNewer tests help doctors identify real food allergy risks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider using component-resolved diagnostics and functional assays to improve specificity in food allergy risk stratification.

This narrative review synthesizes current knowledge on innovative diagnostic techniques for food allergy management. The authors evaluate several advanced modalities, including component-resolved diagnostics (CRD), functional cellular assays such as basophil activation tests (BAT) and mast cell activation tests (MAT), epitope-specific IgE profiling, and allergen-specific IgG4/IgE ratios.

Standard diagnostic tools like skin prick tests (SPT) and serum allergen-specific IgE are noted for high sensitivity but lack specificity, often identifying clinically irrelevant sensitization. In contrast, CRD allows for detailed characterization of molecular sensitization profiles to improve risk stratification. Functional cellular assays provide a direct assessment of IgE-mediated effector cell responses and demonstrate higher diagnostic specificity compared with conventional testing.

While oral food challenges remain the gold standard, they are resource-demanding and carry risks of systemic reactions. The review suggests that integrating innovative diagnostics may improve accuracy and reduce reliance on these high-risk procedures. However, the authors note that technologies such as multi-omics and artificial intelligence are currently emerging and not yet established clinical standards.

Living with a food allergy can be stressful because standard tests are not always accurate. While common skin prick tests and blood tests are very sensitive at finding reactions, they often flag sensitivities that do not actually cause a physical reaction. This makes it hard for doctors to know exactly what a patient can safely eat.

Newer methods like component-resolved diagnostics offer a deeper look. These tests break down the specific proteins in food to see exactly what part of the food causes a problem. Other advanced tests, known as functional cellular assays, measure how the body's cells actually respond to an allergen. These methods have shown higher specificity than traditional testing.

While oral food challenges remain the gold standard for diagnosis, they are difficult to perform and carry risks of serious reactions. These newer diagnostic tools aim to provide more accurate risk information, potentially reducing the need for risky challenges. Because this is a narrative review, these advanced techniques are still being integrated into common practice.

What this means for you:
Newer tests can identify specific food proteins that cause reactions, providing clearer guidance than standard skin tests.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Food allergy (FA) is an immune-mediated adverse reaction to food components (mainly proteins) and represents an increasing global health problem, affecting millions of individuals and imposing substantial clinical, psychosocial, and economic burdens. Accurate diagnosis is essential to prevent life-threatening reactions while avoiding unnecessary dietary restrictions and impaired quality of life. Current diagnostic approaches rely on clinical history, skin prick tests (SPT), measurement of serum allergen-specific IgE (sIgE), and oral food challenges (OFC). However, SPT and sIgE are highly sensitive but lack specificity, frequently identifying clinically irrelevant sensitization, whereas OFC remains the diagnostic gold standard despite being resource-demanding and carrying a substantial risk of systemic reactions. In recent years, several innovative diagnostic approaches have emerged with the aim of improving diagnostic accuracy and reducing reliance on OFC. Component-resolved diagnostics (CRD) enable detailed characterization of molecular sensitization profiles, supporting improved risk stratification and identification of clinically relevant cross-reactivity patterns. Functional cellular assays, including the basophil activation test (BAT) and the mast cell activation test (MAT), offer direct assessment of IgE-mediated effector cell responses and have demonstrated higher diagnostic specificity compared with conventional testing. Epitope-specific IgE profiling and the allergen-specific IgG4/IgE ratio may additionally contribute to a better understanding of disease phenotype and evolution. Furthermore, advances in multi-omics technologies combined with artificial intelligence and machine learning are creating new opportunities for biomarker discovery and predictive modelling in FA. This narrative review summarizes current innovative diagnostic techniques in food allergy, discussing their clinical applications, limitations, and future directions toward more precise and personalized diagnostic approaches.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.